Madeline Camejo, Pharm. D., on behalf of Memorial Regional Hospital South filed on March 9, 2016.; The Petitioner seeks a Declaratory Statement from the Board with regard to whether the ceiling tiles in the IV rooms at the hospital are in compliance ...  

  •  

    DEPARTMENT OF HEALTH

    Board of Pharmacy

    RULE NO.:RULE TITLE:

    64B16-27.797The Standards of Practice for Compounding Sterile Products

    NOTICE IS HEREBY GIVEN that the Board of Pharmacy has received the petition for declaratory statement from Madeline Camejo, Pharm. D., on behalf of Memorial Regional Hospital South filed on March 9, 2016. The petition seeks the agencys opinion as to the applicability of Rule 64B16-27.797, F.A.C., as it applies to the petitioner.

    The Petitioner seeks a Declaratory Statement from the Board with regard to whether the ceiling tiles in the IV rooms at the hospital are in compliance with USP 797 and any standards in sterile compounding required by Board rule or current good manufacturing practices. Except for good cause shown, motions for leave to intervene must be filed within 21 days after the publication of this notice.

    A copy of the Petition for Declaratory Statement may be obtained by contacting: Allison Dudley, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254 or by email at info@floridaspharmacy.gov within 14 days of publication of this notice.

Document Information

Meeting:
Rule 64B16-27.797, F.A.C.
Contact:
Allison Dudley, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254or by email at info@floridaspharmacy.gov within 14 days of publication of this notice.
Related Rules: (1)
64B16-27.797. Standards of Practice for Compounding Sterile Preparations (CSPs)